Literature DB >> 8001595

Alpha interferon has no effect on lidocaine metabolism in the rat.

E Melzer1, E Bardan, I Ronen, Z Krepel, S Bar Meir.   

Abstract

Interferons (IFN) inhibit activity of many isoenzymes of the hepatic microsomal cytochrome P-450 system. This inhibition is species specific. Lidocaine is metabolized by cytochrome P-450 III A 4. We investigated in the rat the effect of rat alpha-IFN on lidocaine elimination and on its extraction by the isolated perfused rat liver. To determine elimination, the femoral artery and vein were cannulated. 24 h later, the conscious rat was given lidocaine through the venous catheter and blood was drawn from the arterial catheter for lidocaine determination every 3 min for 20 min. 7 rats were pre-treated with intramuscular rat alpha-IFN 7.5 x 10(5) U, 24 h prior to the experiment and another 4 rats were given saline i.m. The lidocaine elimination rate constant was unchanged, 0.065 min-1 and 0.063 min-1 for the control and IFN groups, respectively. To investigate lidocaine extraction, the isolated perfused rat liver was used. Perfusate samples from the portal and hepatic veins were drawn at 2 min intervals for 20 min, and lidocaine extraction determined. Extraction was determined in two groups of 6 rats each. The first group served as control and these rats were injected with saline only, while in the second group, the rats were pre-treated with rat alpha-IFN 7.5 x 10(5) U. Lidocaine extraction by the isolated perfused rat liver remained unchanged, 97.0 +/- 0.7% and 94.0 +/- 2.4% in the control and IFN treated groups, respectively. It is concluded that the rat alpha-IFN affects neither the elimination nor the extraction of lidocaine.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8001595     DOI: 10.1007/BF03188835

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  19 in total

Review 1.  The pharmacology and toxicology of the interferons: an overview.

Authors:  G J Mannering; L B Deloria
Journal:  Annu Rev Pharmacol Toxicol       Date:  1986       Impact factor: 13.820

2.  Lack of effect of omeprazole on rat hepatic blood flow.

Authors:  E Melzer; R Bruck; Z Krepel; S Bar-Meir
Journal:  Isr J Med Sci       Date:  1989-12

3.  Rat but not human interferons suppress hepatic oxidative drug metabolism in rats.

Authors:  P I Craig; S J Williams; E Cantrill; G C Farrell
Journal:  Gastroenterology       Date:  1989-10       Impact factor: 22.682

4.  Coordinate modulation of murine hepatic xanthine oxidase activity and the cytochrome P-450 system by interferons.

Authors:  J J Reiners; A R Cantu; T A Rupp
Journal:  J Interferon Res       Date:  1990-04

5.  Omeprazole is an aryl hydrocarbon-like inducer of human hepatic cytochrome P450.

Authors:  D Diaz; I Fabre; M Daujat; B Saint Aubert; P Bories; H Michel; P Maurel
Journal:  Gastroenterology       Date:  1990-09       Impact factor: 22.682

6.  The cimetidine-lidocaine interaction.

Authors:  A B Knapp; W Maguire; G Keren; A Karmen; B Levitt; D S Miura; J C Somberg
Journal:  Ann Intern Med       Date:  1983-02       Impact factor: 25.391

7.  The interaction of omeprazole with rat liver cytochrome P450-mediated monooxygenase reactions in vitro and in vivo.

Authors:  R J Chenery; A Ayrton; H G Oldham; S J Norman; P Standring
Journal:  Biochem Pharmacol       Date:  1988-04-01       Impact factor: 5.858

8.  Effects of interferon-inducing agents on hepatic cytochrome P-450 drug metabolizing systems.

Authors:  G J Mannering; K W Renton; R el Azhary; L B Deloria
Journal:  Ann N Y Acad Sci       Date:  1980       Impact factor: 5.691

9.  Cimetidine and omeprazole have different effects on hepatic extraction of lidocaine in rats.

Authors:  R Bruck; Z Krepel; S Bar-Meir
Journal:  Gastroenterology       Date:  1990-09       Impact factor: 22.682

10.  Depression of cytochrome P-450 and alterations of protein metabolism in mice treated with the interferon inducer polyriboinosinic acid X polyribocytidylic acid.

Authors:  N J Gooderham; G J Mannering
Journal:  Arch Biochem Biophys       Date:  1986-11-01       Impact factor: 4.013

View more
  1 in total

1.  Modification of the P-glycoprotein dependent pharmacokinetics of digoxin in rats by human recombinant interferon-alpha.

Authors:  Makrem Ben Reguiga; Laurence Bonhomme-Faivre; Simone Orbach-Arbouys; Robert Farinotti
Journal:  Pharm Res       Date:  2005-08-16       Impact factor: 4.200

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.